NYT

Key Facts About New York Times Co – What Investors Need to Know

Mid-cap Consumer Discretionary company New York Times Company has moved 0.5% so far today on a volume of 98,968, compared to its average of 1,010,972. In contrast, the S&P 500 index moved 0.0%.

New York Times Company trades -0.94% away from its average analyst target price of $43.58 per share. The 6 analysts following the stock have set target prices ranging from $37.0 to $50.0, and on average have given New York Times Company a rating of hold.

Anyone interested in buying NYT should be aware of the facts below:

  • New York Times Company's current price is 195.7% above its Graham number of $14.6, which implies that at its current valuation it does not offer a margin of safety

  • New York Times Company has moved 33.0% over the last year, and the S&P 500 logged a change of 5.0%

  • Based on its trailing earnings per share of 1.14, New York Times Company has a trailing 12 month Price to Earnings (P/E) ratio of 37.9 while the S&P 500 average is 15.97

  • NYT has a forward P/E ratio of 27.3 based on its forward 12 month price to earnings (EPS) of $1.58 per share

  • The company has a price to earnings growth (PEG) ratio of 2.35 — a number near or below 1 signifying that New York Times Company is fairly valued compared to its estimated growth potential

  • Its Price to Book (P/B) ratio is 4.42 compared to its sector average of 3.12

  • The New York Times Company, together with its subsidiaries, provides news and information for readers and viewers across various platforms worldwide.

  • Based in New York, the company has 5,800 full time employees and a market cap of $7.11 Billion. New York Times Company currently returns an annual dividend yield of 0.9%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS